Global Dry Age-Related Macular Degeneration Market Insights, Forecast to 2029
This report presents an overview of global market for Dry Age-Related Macular Degeneration market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Dry Age-Related Macular Degeneration, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Dry Age-Related Macular Degeneration, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dry Age-Related Macular Degeneration revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Dry Age-Related Macular Degeneration market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Dry Age-Related Macular Degeneration revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Santen Pharmaceuticals, Allergan, Bausch Health, Alimera Science, Phio Pharmaceuticals, Ocumension Therapeutics, Belite Bio, Kubota Vision and Iveric Bio, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Dry Age-Related Macular Degeneration in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Age-Related Macular Degeneration companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Age-Related Macular Degeneration revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Dry Age-Related Macular Degeneration, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Dry Age-Related Macular Degeneration, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dry Age-Related Macular Degeneration revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Dry Age-Related Macular Degeneration market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Dry Age-Related Macular Degeneration revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Santen Pharmaceuticals, Allergan, Bausch Health, Alimera Science, Phio Pharmaceuticals, Ocumension Therapeutics, Belite Bio, Kubota Vision and Iveric Bio, etc.
By Company
- Santen Pharmaceuticals
- Allergan
- Bausch Health
- Alimera Science
- Phio Pharmaceuticals
- Ocumension Therapeutics
- Belite Bio
- Kubota Vision
- Iveric Bio
- Eyestem Research
- Y2 Solution
- Stealth Biotherapeutics
- Oral
- Injectables
- Above 40 Years
- Above 60 Years
- Above 75 Years
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Dry Age-Related Macular Degeneration in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Age-Related Macular Degeneration companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Age-Related Macular Degeneration revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectables
1.3 Market by Application
1.3.1 Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Above 40 Years
1.3.3 Above 60 Years
1.3.4 Above 75 Years
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Dry Age-Related Macular Degeneration Market Perspective (2018-2029)
2.2 Global Dry Age-Related Macular Degeneration Growth Trends by Region
2.2.1 Dry Age-Related Macular Degeneration Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dry Age-Related Macular Degeneration Historic Market Size by Region (2018-2023)
2.2.3 Dry Age-Related Macular Degeneration Forecasted Market Size by Region (2024-2029)
2.3 Dry Age-Related Macular Degeneration Market Dynamics
2.3.1 Dry Age-Related Macular Degeneration Industry Trends
2.3.2 Dry Age-Related Macular Degeneration Market Drivers
2.3.3 Dry Age-Related Macular Degeneration Market Challenges
2.3.4 Dry Age-Related Macular Degeneration Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Dry Age-Related Macular Degeneration by Players
3.1.1 Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023)
3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2018-2023)
3.2 Global Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Dry Age-Related Macular Degeneration, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Dry Age-Related Macular Degeneration Market Concentration Ratio
3.4.1 Global Dry Age-Related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Age-Related Macular Degeneration Revenue in 2022
3.5 Global Key Players of Dry Age-Related Macular Degeneration Head office and Area Served
3.6 Global Key Players of Dry Age-Related Macular Degeneration, Product and Application
3.7 Global Key Players of Dry Age-Related Macular Degeneration, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DRY AGE-RELATED MACULAR DEGENERATION BREAKDOWN DATA BY TYPE
4.1 Global Dry Age-Related Macular Degeneration Historic Market Size by Type (2018-2023)
4.2 Global Dry Age-Related Macular Degeneration Forecasted Market Size by Type (2024-2029)
5 DRY AGE-RELATED MACULAR DEGENERATION BREAKDOWN DATA BY APPLICATION
5.1 Global Dry Age-Related Macular Degeneration Historic Market Size by Application (2018-2023)
5.2 Global Dry Age-Related Macular Degeneration Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dry Age-Related Macular Degeneration Market Size (2018-2029)
6.2 North America Dry Age-Related Macular Degeneration Market Size by Type
6.2.1 North America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
6.2.2 North America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
6.2.3 North America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
6.3 North America Dry Age-Related Macular Degeneration Market Size by Application
6.3.1 North America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
6.3.2 North America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
6.3.3 North America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
6.4 North America Dry Age-Related Macular Degeneration Market Size by Country
6.4.1 North America Dry Age-Related Macular Degeneration Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
6.4.3 North America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Dry Age-Related Macular Degeneration Market Size (2018-2029)
7.2 Europe Dry Age-Related Macular Degeneration Market Size by Type
7.2.1 Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
7.2.2 Europe Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
7.2.3 Europe Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
7.3 Europe Dry Age-Related Macular Degeneration Market Size by Application
7.3.1 Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
7.3.2 Europe Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
7.3.3 Europe Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
7.4 Europe Dry Age-Related Macular Degeneration Market Size by Country
7.4.1 Europe Dry Age-Related Macular Degeneration Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
7.4.3 Europe Dry Age-Related Macular Degeneration Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Dry Age-Related Macular Degeneration Market Size (2018-2029)
8.2 China Dry Age-Related Macular Degeneration Market Size by Type
8.2.1 China Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
8.2.2 China Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
8.2.3 China Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
8.3 China Dry Age-Related Macular Degeneration Market Size by Application
8.3.1 China Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
8.3.2 China Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
8.3.3 China Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Dry Age-Related Macular Degeneration Market Size (2018-2029)
9.2 Asia Dry Age-Related Macular Degeneration Market Size by Type
9.2.1 Asia Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
9.2.2 Asia Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
9.2.3 Asia Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
9.3 Asia Dry Age-Related Macular Degeneration Market Size by Application
9.3.1 Asia Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
9.3.2 Asia Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
9.3.3 Asia Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
9.4 Asia Dry Age-Related Macular Degeneration Market Size by Region
9.4.1 Asia Dry Age-Related Macular Degeneration Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Dry Age-Related Macular Degeneration Market Size by Region (2018-2023)
9.4.3 Asia Dry Age-Related Macular Degeneration Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type
10.2.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application
10.3.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country
10.4.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Santen Pharmaceuticals
11.1.1 Santen Pharmaceuticals Company Details
11.1.2 Santen Pharmaceuticals Business Overview
11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Introduction
11.1.4 Santen Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.1.5 Santen Pharmaceuticals Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Dry Age-Related Macular Degeneration Introduction
11.2.4 Allergan Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.2.5 Allergan Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Dry Age-Related Macular Degeneration Introduction
11.3.4 Bausch Health Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.3.5 Bausch Health Recent Developments
11.4 Alimera Science
11.4.1 Alimera Science Company Details
11.4.2 Alimera Science Business Overview
11.4.3 Alimera Science Dry Age-Related Macular Degeneration Introduction
11.4.4 Alimera Science Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.4.5 Alimera Science Recent Developments
11.5 Phio Pharmaceuticals
11.5.1 Phio Pharmaceuticals Company Details
11.5.2 Phio Pharmaceuticals Business Overview
11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Introduction
11.5.4 Phio Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.5.5 Phio Pharmaceuticals Recent Developments
11.6 Ocumension Therapeutics
11.6.1 Ocumension Therapeutics Company Details
11.6.2 Ocumension Therapeutics Business Overview
11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Introduction
11.6.4 Ocumension Therapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.6.5 Ocumension Therapeutics Recent Developments
11.7 Belite Bio
11.7.1 Belite Bio Company Details
11.7.2 Belite Bio Business Overview
11.7.3 Belite Bio Dry Age-Related Macular Degeneration Introduction
11.7.4 Belite Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.7.5 Belite Bio Recent Developments
11.8 Kubota Vision
11.8.1 Kubota Vision Company Details
11.8.2 Kubota Vision Business Overview
11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Introduction
11.8.4 Kubota Vision Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.8.5 Kubota Vision Recent Developments
11.9 Iveric Bio
11.9.1 Iveric Bio Company Details
11.9.2 Iveric Bio Business Overview
11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Introduction
11.9.4 Iveric Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.9.5 Iveric Bio Recent Developments
11.10 Eyestem Research
11.10.1 Eyestem Research Company Details
11.10.2 Eyestem Research Business Overview
11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Introduction
11.10.4 Eyestem Research Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.10.5 Eyestem Research Recent Developments
11.11 Y2 Solution
11.11.1 Y2 Solution Company Details
11.11.2 Y2 Solution Business Overview
11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Introduction
11.11.4 Y2 Solution Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.11.5 Y2 Solution Recent Developments
11.12 Stealth Biotherapeutics
11.12.1 Stealth Biotherapeutics Company Details
11.12.2 Stealth Biotherapeutics Business Overview
11.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Introduction
11.12.4 Stealth Biotherapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.12.5 Stealth Biotherapeutics Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectables
1.3 Market by Application
1.3.1 Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Above 40 Years
1.3.3 Above 60 Years
1.3.4 Above 75 Years
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Dry Age-Related Macular Degeneration Market Perspective (2018-2029)
2.2 Global Dry Age-Related Macular Degeneration Growth Trends by Region
2.2.1 Dry Age-Related Macular Degeneration Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dry Age-Related Macular Degeneration Historic Market Size by Region (2018-2023)
2.2.3 Dry Age-Related Macular Degeneration Forecasted Market Size by Region (2024-2029)
2.3 Dry Age-Related Macular Degeneration Market Dynamics
2.3.1 Dry Age-Related Macular Degeneration Industry Trends
2.3.2 Dry Age-Related Macular Degeneration Market Drivers
2.3.3 Dry Age-Related Macular Degeneration Market Challenges
2.3.4 Dry Age-Related Macular Degeneration Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Dry Age-Related Macular Degeneration by Players
3.1.1 Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023)
3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2018-2023)
3.2 Global Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Dry Age-Related Macular Degeneration, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Dry Age-Related Macular Degeneration Market Concentration Ratio
3.4.1 Global Dry Age-Related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Age-Related Macular Degeneration Revenue in 2022
3.5 Global Key Players of Dry Age-Related Macular Degeneration Head office and Area Served
3.6 Global Key Players of Dry Age-Related Macular Degeneration, Product and Application
3.7 Global Key Players of Dry Age-Related Macular Degeneration, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DRY AGE-RELATED MACULAR DEGENERATION BREAKDOWN DATA BY TYPE
4.1 Global Dry Age-Related Macular Degeneration Historic Market Size by Type (2018-2023)
4.2 Global Dry Age-Related Macular Degeneration Forecasted Market Size by Type (2024-2029)
5 DRY AGE-RELATED MACULAR DEGENERATION BREAKDOWN DATA BY APPLICATION
5.1 Global Dry Age-Related Macular Degeneration Historic Market Size by Application (2018-2023)
5.2 Global Dry Age-Related Macular Degeneration Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dry Age-Related Macular Degeneration Market Size (2018-2029)
6.2 North America Dry Age-Related Macular Degeneration Market Size by Type
6.2.1 North America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
6.2.2 North America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
6.2.3 North America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
6.3 North America Dry Age-Related Macular Degeneration Market Size by Application
6.3.1 North America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
6.3.2 North America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
6.3.3 North America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
6.4 North America Dry Age-Related Macular Degeneration Market Size by Country
6.4.1 North America Dry Age-Related Macular Degeneration Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
6.4.3 North America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Dry Age-Related Macular Degeneration Market Size (2018-2029)
7.2 Europe Dry Age-Related Macular Degeneration Market Size by Type
7.2.1 Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
7.2.2 Europe Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
7.2.3 Europe Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
7.3 Europe Dry Age-Related Macular Degeneration Market Size by Application
7.3.1 Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
7.3.2 Europe Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
7.3.3 Europe Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
7.4 Europe Dry Age-Related Macular Degeneration Market Size by Country
7.4.1 Europe Dry Age-Related Macular Degeneration Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
7.4.3 Europe Dry Age-Related Macular Degeneration Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Dry Age-Related Macular Degeneration Market Size (2018-2029)
8.2 China Dry Age-Related Macular Degeneration Market Size by Type
8.2.1 China Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
8.2.2 China Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
8.2.3 China Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
8.3 China Dry Age-Related Macular Degeneration Market Size by Application
8.3.1 China Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
8.3.2 China Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
8.3.3 China Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Dry Age-Related Macular Degeneration Market Size (2018-2029)
9.2 Asia Dry Age-Related Macular Degeneration Market Size by Type
9.2.1 Asia Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
9.2.2 Asia Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
9.2.3 Asia Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
9.3 Asia Dry Age-Related Macular Degeneration Market Size by Application
9.3.1 Asia Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
9.3.2 Asia Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
9.3.3 Asia Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
9.4 Asia Dry Age-Related Macular Degeneration Market Size by Region
9.4.1 Asia Dry Age-Related Macular Degeneration Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Dry Age-Related Macular Degeneration Market Size by Region (2018-2023)
9.4.3 Asia Dry Age-Related Macular Degeneration Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type
10.2.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application
10.3.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country
10.4.1 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Santen Pharmaceuticals
11.1.1 Santen Pharmaceuticals Company Details
11.1.2 Santen Pharmaceuticals Business Overview
11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Introduction
11.1.4 Santen Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.1.5 Santen Pharmaceuticals Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Dry Age-Related Macular Degeneration Introduction
11.2.4 Allergan Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.2.5 Allergan Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Dry Age-Related Macular Degeneration Introduction
11.3.4 Bausch Health Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.3.5 Bausch Health Recent Developments
11.4 Alimera Science
11.4.1 Alimera Science Company Details
11.4.2 Alimera Science Business Overview
11.4.3 Alimera Science Dry Age-Related Macular Degeneration Introduction
11.4.4 Alimera Science Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.4.5 Alimera Science Recent Developments
11.5 Phio Pharmaceuticals
11.5.1 Phio Pharmaceuticals Company Details
11.5.2 Phio Pharmaceuticals Business Overview
11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Introduction
11.5.4 Phio Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.5.5 Phio Pharmaceuticals Recent Developments
11.6 Ocumension Therapeutics
11.6.1 Ocumension Therapeutics Company Details
11.6.2 Ocumension Therapeutics Business Overview
11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Introduction
11.6.4 Ocumension Therapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.6.5 Ocumension Therapeutics Recent Developments
11.7 Belite Bio
11.7.1 Belite Bio Company Details
11.7.2 Belite Bio Business Overview
11.7.3 Belite Bio Dry Age-Related Macular Degeneration Introduction
11.7.4 Belite Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.7.5 Belite Bio Recent Developments
11.8 Kubota Vision
11.8.1 Kubota Vision Company Details
11.8.2 Kubota Vision Business Overview
11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Introduction
11.8.4 Kubota Vision Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.8.5 Kubota Vision Recent Developments
11.9 Iveric Bio
11.9.1 Iveric Bio Company Details
11.9.2 Iveric Bio Business Overview
11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Introduction
11.9.4 Iveric Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.9.5 Iveric Bio Recent Developments
11.10 Eyestem Research
11.10.1 Eyestem Research Company Details
11.10.2 Eyestem Research Business Overview
11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Introduction
11.10.4 Eyestem Research Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.10.5 Eyestem Research Recent Developments
11.11 Y2 Solution
11.11.1 Y2 Solution Company Details
11.11.2 Y2 Solution Business Overview
11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Introduction
11.11.4 Y2 Solution Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.11.5 Y2 Solution Recent Developments
11.12 Stealth Biotherapeutics
11.12.1 Stealth Biotherapeutics Company Details
11.12.2 Stealth Biotherapeutics Business Overview
11.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Introduction
11.12.4 Stealth Biotherapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023)
11.12.5 Stealth Biotherapeutics Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injectables
Table 4. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Dry Age-Related Macular Degeneration Market Share by Region (2018-2023)
Table 8. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Dry Age-Related Macular Degeneration Market Share by Region (2024-2029)
Table 10. Dry Age-Related Macular Degeneration Market Trends
Table 11. Dry Age-Related Macular Degeneration Market Drivers
Table 12. Dry Age-Related Macular Degeneration Market Challenges
Table 13. Dry Age-Related Macular Degeneration Market Restraints
Table 14. Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Dry Age-Related Macular Degeneration Revenue Share by Players (2018-2023)
Table 16. Global Top Dry Age-Related Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2022)
Table 17. Global Dry Age-Related Macular Degeneration Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Dry Age-Related Macular Degeneration Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Dry Age-Related Macular Degeneration, Headquarters and Area Served
Table 20. Global Key Players of Dry Age-Related Macular Degeneration, Product and Application
Table 21. Global Key Players of Dry Age-Related Macular Degeneration, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type (2018-2023)
Table 25. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type (2024-2029)
Table 27. Global Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Dry Age-Related Macular Degeneration Revenue Share by Application (2018-2023)
Table 29. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Dry Age-Related Macular Degeneration Revenue Share by Application (2024-2029)
Table 31. North America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Dry Age-Related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Dry Age-Related Macular Degeneration Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 63. Santen Pharmaceuticals Company Details
Table 64. Santen Pharmaceuticals Business Overview
Table 65. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product
Table 66. Santen Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 67. Santen Pharmaceuticals Recent Developments
Table 68. Allergan Company Details
Table 69. Allergan Business Overview
Table 70. Allergan Dry Age-Related Macular Degeneration Product
Table 71. Allergan Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 72. Allergan Recent Developments
Table 73. Bausch Health Company Details
Table 74. Bausch Health Business Overview
Table 75. Bausch Health Dry Age-Related Macular Degeneration Product
Table 76. Bausch Health Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 77. Bausch Health Recent Developments
Table 78. Alimera Science Company Details
Table 79. Alimera Science Business Overview
Table 80. Alimera Science Dry Age-Related Macular Degeneration Product
Table 81. Alimera Science Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 82. Alimera Science Recent Developments
Table 83. Phio Pharmaceuticals Company Details
Table 84. Phio Pharmaceuticals Business Overview
Table 85. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product
Table 86. Phio Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 87. Phio Pharmaceuticals Recent Developments
Table 88. Ocumension Therapeutics Company Details
Table 89. Ocumension Therapeutics Business Overview
Table 90. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product
Table 91. Ocumension Therapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 92. Ocumension Therapeutics Recent Developments
Table 93. Belite Bio Company Details
Table 94. Belite Bio Business Overview
Table 95. Belite Bio Dry Age-Related Macular Degeneration Product
Table 96. Belite Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 97. Belite Bio Recent Developments
Table 98. Kubota Vision Company Details
Table 99. Kubota Vision Business Overview
Table 100. Kubota Vision Dry Age-Related Macular Degeneration Product
Table 101. Kubota Vision Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 102. Kubota Vision Recent Developments
Table 103. Iveric Bio Company Details
Table 104. Iveric Bio Business Overview
Table 105. Iveric Bio Dry Age-Related Macular Degeneration Product
Table 106. Iveric Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 107. Iveric Bio Recent Developments
Table 108. Eyestem Research Company Details
Table 109. Eyestem Research Business Overview
Table 110. Eyestem Research Dry Age-Related Macular Degeneration Product
Table 111. Eyestem Research Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 112. Eyestem Research Recent Developments
Table 113. Y2 Solution Company Details
Table 114. Y2 Solution Business Overview
Table 115. Y2 Solution Dry Age-Related Macular Degeneration Product
Table 116. Y2 Solution Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 117. Y2 Solution Recent Developments
Table 118. Stealth Biotherapeutics Company Details
Table 119. Stealth Biotherapeutics Business Overview
Table 120. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product
Table 121. Stealth Biotherapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 122. Stealth Biotherapeutics Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injectables
Table 4. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Dry Age-Related Macular Degeneration Market Share by Region (2018-2023)
Table 8. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Dry Age-Related Macular Degeneration Market Share by Region (2024-2029)
Table 10. Dry Age-Related Macular Degeneration Market Trends
Table 11. Dry Age-Related Macular Degeneration Market Drivers
Table 12. Dry Age-Related Macular Degeneration Market Challenges
Table 13. Dry Age-Related Macular Degeneration Market Restraints
Table 14. Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Dry Age-Related Macular Degeneration Revenue Share by Players (2018-2023)
Table 16. Global Top Dry Age-Related Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2022)
Table 17. Global Dry Age-Related Macular Degeneration Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Dry Age-Related Macular Degeneration Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Dry Age-Related Macular Degeneration, Headquarters and Area Served
Table 20. Global Key Players of Dry Age-Related Macular Degeneration, Product and Application
Table 21. Global Key Players of Dry Age-Related Macular Degeneration, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type (2018-2023)
Table 25. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Dry Age-Related Macular Degeneration Revenue Market Share by Type (2024-2029)
Table 27. Global Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Dry Age-Related Macular Degeneration Revenue Share by Application (2018-2023)
Table 29. Global Dry Age-Related Macular Degeneration Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Dry Age-Related Macular Degeneration Revenue Share by Application (2024-2029)
Table 31. North America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Dry Age-Related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Dry Age-Related Macular Degeneration Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size by Country (2024-2029) & (US$ Million)
Table 63. Santen Pharmaceuticals Company Details
Table 64. Santen Pharmaceuticals Business Overview
Table 65. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product
Table 66. Santen Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 67. Santen Pharmaceuticals Recent Developments
Table 68. Allergan Company Details
Table 69. Allergan Business Overview
Table 70. Allergan Dry Age-Related Macular Degeneration Product
Table 71. Allergan Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 72. Allergan Recent Developments
Table 73. Bausch Health Company Details
Table 74. Bausch Health Business Overview
Table 75. Bausch Health Dry Age-Related Macular Degeneration Product
Table 76. Bausch Health Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 77. Bausch Health Recent Developments
Table 78. Alimera Science Company Details
Table 79. Alimera Science Business Overview
Table 80. Alimera Science Dry Age-Related Macular Degeneration Product
Table 81. Alimera Science Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 82. Alimera Science Recent Developments
Table 83. Phio Pharmaceuticals Company Details
Table 84. Phio Pharmaceuticals Business Overview
Table 85. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product
Table 86. Phio Pharmaceuticals Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 87. Phio Pharmaceuticals Recent Developments
Table 88. Ocumension Therapeutics Company Details
Table 89. Ocumension Therapeutics Business Overview
Table 90. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product
Table 91. Ocumension Therapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 92. Ocumension Therapeutics Recent Developments
Table 93. Belite Bio Company Details
Table 94. Belite Bio Business Overview
Table 95. Belite Bio Dry Age-Related Macular Degeneration Product
Table 96. Belite Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 97. Belite Bio Recent Developments
Table 98. Kubota Vision Company Details
Table 99. Kubota Vision Business Overview
Table 100. Kubota Vision Dry Age-Related Macular Degeneration Product
Table 101. Kubota Vision Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 102. Kubota Vision Recent Developments
Table 103. Iveric Bio Company Details
Table 104. Iveric Bio Business Overview
Table 105. Iveric Bio Dry Age-Related Macular Degeneration Product
Table 106. Iveric Bio Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 107. Iveric Bio Recent Developments
Table 108. Eyestem Research Company Details
Table 109. Eyestem Research Business Overview
Table 110. Eyestem Research Dry Age-Related Macular Degeneration Product
Table 111. Eyestem Research Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 112. Eyestem Research Recent Developments
Table 113. Y2 Solution Company Details
Table 114. Y2 Solution Business Overview
Table 115. Y2 Solution Dry Age-Related Macular Degeneration Product
Table 116. Y2 Solution Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 117. Y2 Solution Recent Developments
Table 118. Stealth Biotherapeutics Company Details
Table 119. Stealth Biotherapeutics Business Overview
Table 120. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product
Table 121. Stealth Biotherapeutics Revenue in Dry Age-Related Macular Degeneration Business (2018-2023) & (US$ Million)
Table 122. Stealth Biotherapeutics Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Dry Age-Related Macular Degeneration Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injectables Features
Figure 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Dry Age-Related Macular Degeneration Market Share by Application: 2022 VS 2029
Figure 7. Above 40 Years Case Studies
Figure 8. Above 60 Years Case Studies
Figure 9. Above 75 Years Case Studies
Figure 10. Dry Age-Related Macular Degeneration Report Years Considered
Figure 11. Global Dry Age-Related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dry Age-Related Macular Degeneration Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dry Age-Related Macular Degeneration Market Share by Region: 2022 VS 2029
Figure 14. Global Dry Age-Related Macular Degeneration Market Share by Players in 2022
Figure 15. Global Top Dry Age-Related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dry Age-Related Macular Degeneration Revenue in 2022
Figure 17. North America Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 19. North America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 20. North America Dry Age-Related Macular Degeneration Market Share by Country (2018-2029)
Figure 21. United States Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 25. Europe Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 26. Europe Dry Age-Related Macular Degeneration Market Share by Country (2018-2029)
Figure 27. Germany Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 35. China Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 36. Asia Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 38. Asia Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 39. Asia Dry Age-Related Macular Degeneration Market Share by Region (2018-2029)
Figure 40. Japan Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Country (2018-2029)
Figure 50. Brazil Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Santen Pharmaceuticals Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 57. Allergan Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 58. Bausch Health Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 59. Alimera Science Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 60. Phio Pharmaceuticals Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 61. Ocumension Therapeutics Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 62. Belite Bio Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 63. Kubota Vision Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 64. Iveric Bio Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 65. Eyestem Research Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 66. Y2 Solution Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 67. Stealth Biotherapeutics Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Dry Age-Related Macular Degeneration Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injectables Features
Figure 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Dry Age-Related Macular Degeneration Market Share by Application: 2022 VS 2029
Figure 7. Above 40 Years Case Studies
Figure 8. Above 60 Years Case Studies
Figure 9. Above 75 Years Case Studies
Figure 10. Dry Age-Related Macular Degeneration Report Years Considered
Figure 11. Global Dry Age-Related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dry Age-Related Macular Degeneration Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dry Age-Related Macular Degeneration Market Share by Region: 2022 VS 2029
Figure 14. Global Dry Age-Related Macular Degeneration Market Share by Players in 2022
Figure 15. Global Top Dry Age-Related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dry Age-Related Macular Degeneration Revenue in 2022
Figure 17. North America Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 19. North America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 20. North America Dry Age-Related Macular Degeneration Market Share by Country (2018-2029)
Figure 21. United States Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 25. Europe Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 26. Europe Dry Age-Related Macular Degeneration Market Share by Country (2018-2029)
Figure 27. Germany Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 35. China Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 36. Asia Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 38. Asia Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 39. Asia Dry Age-Related Macular Degeneration Market Share by Region (2018-2029)
Figure 40. Japan Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Dry Age-Related Macular Degeneration Market Share by Country (2018-2029)
Figure 50. Brazil Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Dry Age-Related Macular Degeneration Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Santen Pharmaceuticals Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 57. Allergan Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 58. Bausch Health Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 59. Alimera Science Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 60. Phio Pharmaceuticals Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 61. Ocumension Therapeutics Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 62. Belite Bio Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 63. Kubota Vision Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 64. Iveric Bio Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 65. Eyestem Research Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 66. Y2 Solution Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 67. Stealth Biotherapeutics Revenue Growth Rate in Dry Age-Related Macular Degeneration Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
